Graphical Abstract Keywords Insulin resistance, Lipid metabolism, Metabolic dysfunction-associated steatotic liver disease, MASLD, Oxidative stress, Silent information regulator 1, SIRT1, Therapeutic targeting Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver condition closely linked to metabolic abnormalities
A new survey report from the International Foundation of Employee Benefit Plans reveals U.S
What matters is whether a physician actually shaped the formulation: the dosing, ingredient choices, and GLP-1-specific design
As a result, patients experience tighter, firmer skin with improved texture and reduced wrinkles
For people whose hair loss is driven by insulin resistance and metabolic dysfunction, tirzepatide may actually help rather than harm
(2001) 281:R96070